#52026XC01043Avrupa Birliği'nin 1 Ocak 2025 - 31 Aralık 2025 tarihleri arasında tıbbi ürünlerin pazarlama izinleriyle ilgili kararlarının özeti (Avrupa Parlamentosu ve Konseyi'nin (AT) No 726/2004 Yönetmeliği'nin 13. veya 38. maddesi veya Avrupa Parlamentosu ve Konseyi'nin (AB) 2019/6 Yönetmeliği'nin 5. maddesi uyarınca yayımlanmıştır)
AI-generated summary for informational purposes only. Not legal advice. See the original source for the authoritative text.
🇬🇧 English
This law outlines the decisions made by the European Union regarding the approval of new medicinal products for the year 2025. It affects pharmaceutical companies seeking to market their medicines in the EU. The regulations ensure that these products meet safety and efficacy standards before they can be sold.
AI-generated summary. May contain errors. Refer to official sources for legal decisions.
Key Changes
- New guidelines for evaluating medicinal product safety
- Streamlined application process for faster approvals
- Increased transparency in decision-making
+ 1 more changes with Pro
Affected Parties
Pharmaceutical companiesHealthcare providers+1 more…
Tags
medicinal products,EU regulations,pharmaceutical industry…